Skip to content
Recall Observatory FDA recall evidence

Drug product

Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile Suspension, Manufactured by: Cipla Ltd., India, Manufactured for Cipla USA Inc., Warren NJ, NDC# 69097-318-86.

D-1545-2022

September 15, 2022

Class II

Product summary

Firm
CIPLA
Event
Event 90864
Status
Terminated
Classification
Class II
Quantity
641,160 ampules
Official record key
drug-enforcement:D-1545-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot #s: GA20080, GA20081, GA20094, Exp. 01/2024

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility